Impressive Continuous Complete Response after Mogamulizumab in a Heavily Pretreated Sézary Syndrome Patient

BACKGROUND: Sézary syndrome (SS) is a rare lymphoproliferative neoplasm, almost incurable outside the setting of allogeneic transplantable patients. The prognosis for relapsed/refractory patients remains poor, as the available drugs confer short-lasting remission. In this setting, the anti-chemokine...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mediterr J Hematol Infect Dis
Autores principales: Lolli, Ginevra, Casadei, Beatrice, Argnani, Lisa, Nanni, Laura, Cavo, Michele, Zinzani, Pier Luigi
Formato: Artigo
Lenguaje:Inglês
Publicado: Università Cattolica del Sacro Cuore 2020
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340218/
https://ncbi.nlm.nih.gov/pubmed/32670518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2020.040
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares